Boston Scientific Q3 2026 sales up 1.5% to $5.14b, profit down
Boston Scientific reported Q3 2026 net sales of $5.138 billion, a 1.5% increase. However, GAAP EPS dropped to $0.40 from $0.51 a year ago due to a cybersecurity incident. Adjusted EPS was $0.73.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed